Orthopedic Braces and Supports Market - Growth rate, Latest Trend and Forecast 2027

The Global Orthopedic Braces and Supports Market is estimated to reach USD 4.6 billion by 2027 from USD 3.4 billion in 2022, at a CAGR of 5.8% during the forecast period (2022-2027).

The Global Orthopedic Braces and Supports Market is estimated to reach USD 4.6 billion by 2027 from USD 3.4 billion in 2022, at a CAGR of 5.8% during the forecast period (2022-2027). Growth in the orthopedic braces and supports market is mainly driven by the increasing prevalence of orthopedic diseases disorders, continuous product commercialization, greater product affordability and market availability, rising number of sports and accident-related injuries, and growing public awareness of preventive care. Increased sales of off-the-shelf and online products, and the expansion and promotion initiatives undertaken by major product manufacturers are also expected to provide a wide range of growth opportunities for players in the market. On the other hand, the limited patient qualification for bracing-mediated orthopedic treatment, limited clinical evidence to support the therapeutic efficacy of orthopedic braces, and the high adoption of pain medications are the major factors expected to limit market growth to a certain extent in the coming years.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=24806829

Key Market Players

The vendors operating in the orthopedic braces and supports market include DJO Finance LLC (US), Ossur HF (Iceland), Breg, Inc. (US), Bauerfeind AG (Germany), and Essity (Sweden) were the top five players in the global orthopedic braces and supports market. Other prominent players operating in this market include 3M (USA), Ottobock Holding GmbH (Germany), Thuasne Group (France), Zimmer Biomet Holdings, Inc. (US), ALCARE (Japan), Bird Cronin, Inc. (US), Nippon and Sigmax (Japan), and Becker Orthopedic (US), among others.

Drivers:

The incidence of orthopedic diseases disorders is expected to increase further in the coming years with the rising prevalence of obesity and related lifestyle disorders, as obese individuals are at a greater risk of orthopedic musculoskeletal injuries as well as diabetes. Orthopedic braces and supports offer several benefits, such as better affordability, higher efficacy, greater patient comfort, and ease of use compared to conventional products. Due to these benefits, key players are increasingly developing specialized products for the treatment of various orthopedic diseases as well as to address the unmet market needs.

Restraints:

Bracing and support products are utilized to effectively manage orthopedic disorders and diseases, with physicians and orthopedic surgeons considering these products clinically necessary for specific conditions. However, in several cases (depending on the severity of the disease and its side effects as well as the patient’s physiology age), patients do not qualify for bracing products.

Innovative orthopedic braces are increasingly being adopted by major end-user facilities (such as hospitals, surgical centers, and orthopedic clinics) across developed markets such as the US, Germany, the UK, and Japan. However, end-user facilities across emerging and less-developed markets are reluctant to adopt novel products due to a lack of awareness and affordability. These users also prefer to utilize traditional/well-established products with proven clinical evidence to support their therapeutic/diagnostic role.

Opportunities:

Specific orthopedic braces can only be used under the supervision of medical practitioners or orthopedic technicians as they require customization or product alteration according to patient features. However, some braces (such as ankle braces, wrist/hand braces, shoulder braces, elbow braces, and facial braces) are increasingly being sold by retailers (off-the-shelf) and e-commerce websites since their use does not require supervision. Patients regularly use such products to prevent injuries.

Major product manufacturers are undertaking strategic initiatives to increase their brand visibility and product awareness among key end users (such as medical professionals, patients, and physiotherapists) across major healthcare markets worldwide.

Get Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=24806829

Challenges:

Topical, oral, and parenteral pain medications are widely used to effectively manage pain associated with musculoskeletal disorders such as tendinitis, carpal tunnel syndrome, and osteoarthritis. Although orthopedic braces are used as part of a noninvasive approach for pain management during compression therapy (cold, hot, or conventional compression therapy), the adoption of pain medication for such applications is high owing to the low awareness about the benefits of orthopedic braces as well as the unfavorable reimbursement scenario for these products, creating a challenge for this market.

By Product

  • Knee Braces and Supports
  • Ankle Braces and Supports
  • Foot Walkers and Orthoses
  • Hip, Back, And Spine Braces and Supports
  • Shoulder Braces and Supports
  • Elbow Braces and Supports
  • Hand Wrist Braces and Supports
  • Facial Braces and Supports

By Type

  • Soft Elastic Braces and Supports
  • Hard Braces and Supports
  • Hinged Braces and Supports

Recent Developments:

In July 2021, DJO LLC (US), renewed its partnership with USA Lacrosse. DJO has been the Official Sports Brace of USA Lacrosse and the US National Teams since 2017; the renewal extends the partnership to 2024.

In July 2021, Ossur HF (Iceland) launched the Rebound Post-Op Elbow Brace.

In Feb 2021, Breg, Inc. (US) launched within the spinal braces segment - 15 new products of the Pinnacle and the Ascend Portfolio.

In June 2020, DJO LLC (US) launched the X-ROM Post-Op Knee Brace.

Get 10% Free Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=24806829

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: [email protected]


Healthcare101

248 Blog posts

Comments